Grifols’ Innovation Strategy in the Plasma Medicine Space
XTalks
DECEMBER 12, 2023
It’s all part of a deep-seated commitment to innovation and its role as the company’s growth engine. Our pipeline, for example, includes a new class of recombinant antibodies. Right now, they are doing what is probably the most advanced work in the field of polyclonal recombinant antibody therapies.
111 
Let's personalize your content